Skip to main content
All lobbying filings

Hooper, Lundy & Bookman, P.C.

Hooper, Lundy & Bookman, P.C. filed a Q2 report for Government Counsel, LLC (OBO) Prime Therapeutics on July 19, 2026, reporting $10,000 in lobbying income.

Lobbying for Government Counsel, LLC (OBO) Prime Therapeutics · ​Public Policy and Government Advisory Firm

As filed: HOOPER, LUNDY & BOOKMAN, P.C. for GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS.

All filings by Hooper, Lundy & Bookman, P.C. · Everything Government Counsel, LLC (OBO) Prime Therapeutics has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Florida

Official filing document

 Lobbyists on this filing 1
  • LISA LAYMAN
    Previously held: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

HCR: S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).

 Bills named in this filing 1
  • S. 2355
    Patients Deserve Price Tags Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem